Upload
edward-howard
View
230
Download
2
Tags:
Embed Size (px)
Citation preview
Introduction to Rheumatologic Disease
Art Weiss
August 31, 2011
Definition:
Rheumatologic (or Rheumatic) Disease: diseases characterized by pain and inflammationin joints and connective tissues, often referred toas “collagen-vascular diseases”.
Diversity of Rheumatologic Diseases:Common and Uncommon Diseases Involving
Inflammatory and Immune Responses
Inflammatory Diseases (innate immunity)Osteoarthritis*Gout*Pseudogout
Immunologically-Mediated Diseases (adaptive immunity)Rheumatoid Arthritis*Systemic Lupus Erythematosus*Spondyloarthropathies*
Ankylosing spondylitisReactive Arthritis (Reiter’s Syndrome)Psoriatic ArthritisSpondylitis associated with IBD
Sjogren’s SyndromePolymositis/DematomyositisLyme DiseaseRheumatic FeverBehcet’s SyndromeSystemic Sclerosis (Scleroderma)Wegener’s GranulomatosisGiant Cell Arteritis*
* Diseases that will be covered in depth later in lecture of this course.
The Painter’s FamilyJacob Jordaens (1593-1678)
Evidence of: Rheumatoid Arthritis
The Virgin with Canon vanDer Paele, 1436Jan van Eyck (1385-1440)
Evidence of:Temporal (Giant Cell) Arteritis
Introduction to Rheumatology: Historical Perspective
Importance and Impact of Rheumatologic Disease
Prevalence (per 100,000)
Male FemaleRheumatoid Arthritis 440 1,100Ankylosing Spondylitis 197 73Gout 980 230SLE 7 32Scleroderma 1 5Osteoarthritis 3,470 5,870
All Musculoskeletal conditions 15,510 20,720
CDC: Census Bureau 2004
Enormous Impact of Arthritis
In 2003, the total cost of arthritis was $128 billion—nearly $81 billion in direct costs and $47 billion in indirect costs, equal to 1.2% of the 2003 U.S. gross domestic product. Arthritis is not just an old person’s disease. Nearly two-thirds of people with arthritis are younger than 65. Although arthritis affects children and people of all racial and ethnic groups, it is more common among women and older adults. - CDC
The Normal Joint
The Normal Synovium
Function of Normal Synovium:• maintenance of intact non-adherent tissue surface• lubrication of cartilage• control of synovial fluid volume and composition (plasma and hyaluronan)• nutrition of chondrocytes within joints
Arthralgia vs Arthritis
Arthralgia: Joint pain (there may not be any inflammation)
Arthritis: Inflammation of the Joint
- Pain- Redness- Swelling- Increased warmth- Fluid accumulation (synovial effusion)- Stiffness (especially in the AM)
Choy, E. H.S. et al. N Engl J Med 2001;344:907-916
Pathogenesis of Rheumatoid Arthritis
Inflammed synovial tissue (synovitis)• Villous hyperplasia• Intimal cell proliferation• Inflammatory cell infiltration T cells, B cells, macrophages and plasma cells• Production of cytokines and proteases• Increased vascularity• Self-amplifying process
Modified from Choy, E. H.S. et al. N Engl J Med 2001;344:907-916
Multiple Cell Types and Cytokine Signaling Pathways Involved in Chronic Inflammatory Arthritis
Key cytokines in ChronicInflammatory Arthritis:
TNF- IL-1
IFN-IL-6OPGL (RANK-ligand)IL-17
Naïve T cell
Multiple T cell Subsets Contribute to the Development of Arthritis adapted from McInnes and Schett, Nat. Rev. Immunol., 7:429-442, 2007
CD4
CD28
Key Factors that Regulate Osteoclast Differentiationin Arthritis
Nature Reviews Immunology, 2007
Th17 Cells Contribute to Cartilage Distructionin Additional Ways
Nature Reviews Immunology, 2007
Progressive Chronic Inflammation Can Lead to Joint Destruction
Early Arthritis - soft tissue swelling,especially around the PIP joints
Chronic inflammationin the joint leads to bone destructionevident as erosions
Prolonged severechronic arthritisleads to deformity anddisability.
What is the Immune Response Directed Against?Very Diverse Autoantigens
Lyme Disease:Residual OrganismsCross-reactive antigens
Rheumatoid Arthritis:Type II collagenIgG (rheumatoid factor)Citrullinated proteins (arginine residues modified)
Systemic Lupus Erythematosus (intra- and extra-cellular antigens):Nuclear antigens:
Ribonuclear proteinsHistonesdsDNA
Leukocyte cell surface antigensCardiolipin
Rheumatoid Factors: An Auto-antibody to Self IgG Fc
HomogeneousANA
NucleolarANA
Speckled ANA
CentriolarANA
Multiple Nuclear Antigens Can be Detected by Autoantibodies in Sera of Patients with Rheumatic Diseases
Why does tolerance fail?
Why do people develop auto-immunerheumatologic diseases?
Factors that Predispose an Individual to Rheumatologic Diseases
I. Susceptibility Genes
A. MHC class I (i.e., HLA-B27 in spondyloarthropathies) B. MHC class II (i.e. HLA-DR4 in RA) C. Complement deficiency states (i.e., C2 or C4 deficiency in SLE) D. Fc Receptor Polymorphisms (i.e., FcR deficiency in SLE) E. PTPN22, a tyrosine phosphatase, polymorphism associated with rheumatoid arthritis, SLE, others F. Gender (female:male cases of SLE are 9:1) G. Others (48 susceptibility loci for SLE in the genome)
Genetic Basis of Rheumatic Diseases:
Genotype contributes to rheumatic disease susceptibility
________ Twin Studies____________ Monozygotic Dizygotic Genetic Component
Disease Concordance (%) Concordance (%) Explained by HLA (%)
Rheumatoid Arthritis 15-34 0-6 35
SLE 25-57 0-3
Ankylosing Spondylitis 50-75 13-18 37______________________________________________________________________________
Most often rheumatic diseases are polygenic. A certaingenotype predisposes an individual to a disease, but does not make disease development a certainty.
Genome Wide Scan of SNPs Associated with RA
Plenge et al. NEJM. 357:1199 (2007)
A common polymorphism in PTPN22 confers susceptibility to multiple autoimmune diseases
- RA, Lupus, T1 diabetes, Hashimoto’s Thyroiditis
Whole genome scan for RA PTPN22 is #2 hit Odds ratio < 2
II. Environmental Factors
A. Viral infect ions (hepatitis B, hepatitis C, others) B. Bacterial infections (Shigella, Salmonella, gp A strep., etc.) C. Drugs (procainamide, dilantin, others) D. Toxins (heavy metals, others) E. UV-light (i.e., in SLE)
III. Status of the Immune System
A. Relative state of activation B. Relative balance of Th1 and Th2 C. History of previous responses
IV. Status of Targ et Organ/Tissue
A. Visibi lity of autoantigen (privileged sites, intra- vs extra-cellular, etc) B. Expression level of autoantigen C. Expression level of MHC D. Costimulatory molecules E. Ongoing inflammation
Multiple Factors Contribute to the Development of ArthritisNature Reviews Immunology, 2007
Clinical Features
Acute vs Chronic Inflammatory Arthritis
Acute ArthritisRapid onset (hours or days)Severe symptomsMediated by components of innate immune response, especially neutrophils (proteases, leukotrienes, prostaglandins, etc.)Can result in rapid joint destruction Can also evolve into chronic diseaseExamples: Gout and Infectious Arthritis
Chronic ArthritisMore gradual onset (days to weeks)Symptoms are more moderate, AM stiffness is a prominent symptomMediated by the adaptive immune response, especially T cells
and macrophages - a Th1 diseaseCytokines and chronic inflammation lead to joint remodeling and destruction via erosionsExamples: Rheumatoid Arthritis, Ankylosing Spondylitis, SLE, Lyme Disease
Pattern of Joint Involvement is Distinct in Different Diseases
Monoarticular vs PolyarticularMono PolyGout RAInfection SLEReactive
Joint distributionPIPs and MCPs: RA, SLEDIPs: Osteoarthritis, PsoriaticMTP: Gout
Symmetrical vs AsymmetricalSymmetrical: RA, SLEAsymmetrical: Psoriatic, Reactive
Rheumatic Disease Are Systemic Inflammatory Diseases withan Underlying Immune or Inflammatory Pathogenesis
Disease Organ System Involvement
Rheumatoid Arthritis Joints (arthritis)Vessels (vasculitis)Eyes (scleritis and episcleritis)Hematologic (anemia, thrombocytosis)Pulmonary (plueritis, alveolitis, etc,)
Systemic Lupus Erythematosus (SLE) Joints (arthritis)Skin (photosensitive rash)Serosa (pericardium & pleura)Hematology (anemia, thrombocytopenia)Kidneys (glomerulonephritis)Lungs (interstitial disease, alveolitis, etc.)CNS (cognitive dysfunction, seizures, etc.)
Lyme Disease Joints (arthritis)Skin (Erythema chronicum migrans)Heart (carditis)CNS (meningo-encephalitis)
Rheumatoid Arthritis is Systemic Inflammatory Disease
SLE is a Systemic Inflammatory Disease
Therapeutic Strategies
Reagents that blunt inflammation but don’t have effects on disease progression:AspirinNonsteroidal anti-inflammatory drugs (NSAIDs)
Non-selective and selective COX-2 antagonistsSteroids (prednisone)
Disease Modifying Anti-Rheumatic Drugs (DMARDs):Broad Acting:
MethotrexateHydroxychloroquinAzathoprineCyclophosphamideCyclosporin
More selective biologics:TNF antagonistsIL-6R antagonistsIL-1R antagonistsanti-B cell (CD20) therapycostimulatory inhibitors (CTLA4-Ig)Intravenous Immunoglobulin (iv Ig)
Choy, E. H.S. et al. N Engl J Med 2001;344:907-916
Methods of Blocking the Activity of an Inflammatory Cytokine
Blocking CD28-dependent Costimulation
Abatacept is a fusion of the extracellular domain of CTLA-4 (similar to CD28 but with higher affinity for CD80 and CD86) with the Fc fragment of IgG1 (for effector function and to prolong half-life)
From: Morelandhttp://www.medscape.com/viewprogram/3415_pnt
Biological TherapeuticsTargets, Rationale, Status